The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found an herbal supplement that made their migraines less intense.

Founder of Doable Health & Fitness Shares Her Practical Approach to Strength, Glucose Balance, and Sustainable ...

Stopping GLP-1 drugs like Wegovy/Ozempic or Zepbound/Mounjaro may raise heart attack, stroke, and death risk, BMJ Medicine study finds. Read more here.

This common blood test indicates whether or not your body has been coping well with sugar over the last few months.

If social media is to be believed, adding this savoury soup to your morning routine could be beneficial for your heart health ...

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals ...

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...